APOE and Alzheimer disease: By exploring early phase arterial and late phase capillary perfusion in cognitively impaired subjects, one group WMH+ APOE 4+ (genetically disposed for early AD) versus WMH+ APOE—subjects not predisposed for early AD, may distinguish arterial physiological differences between the two groups [12,29,30,31] [Figure 1].